
(Adds shares in paragraph 2, details in paragraph 3) Oct 30 (Reuters) – The US Food and Drug Administration has approved Inovio Pharmaceuticals' treatment for a rare respiratory condition, the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
S&P Global revises Meta's outlook to 'negative' on AI spending, cash flow worries
Oct 30 (Reuters) - S&P Global Ratings on Friday revised its outlook on Meta Platforms…
Midterm US elections, earnings, jobs data loom for AI-wary stock market
By Lewis Krauskopf NEW YORK, Oct 30 (Reuters) - US midterm elections, a heavy slate…
Vacherot, Fritz, Lehecka and Struff make the Swiss Indoors semis
VIDEO SHOWS: ATP 500 SWISS INDOORS BASEL QUARTER-FINALS HIGHLIGHTS RESENDING WITH COMPLETE SCRIPT SHOWS: BASEL,…